Algae complex capsule
Algae complex capsule, licence 80123445: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- BOOMHUE Bright 2x, Bright 2x, CTC Health Care Bright 2x, MEIKAXIONG Bright 2x, REAPS Bright 2x
- Licence holder
- JEM Bioscience Ltd.
- NPN or DIN-HM
- 80123445
- Status
- Active licence
- Licence date
- 8 March 2023
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 22 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : d-alpha tocophérol | 14.0 mg AT | Not calculated |
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 20.0 mg | Not calculated |
| bêta-Carotène-3,3'-diol tout trans Source : Zeaxanthin | 2.0 mg | Not calculated |
| bêta-Carotène-3,3'-diol tout trans Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 2.0 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 22.0 microgram | 22 µg |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Dioxyde de titane, Hydroxypropyl méthylcellulose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support/maintain eye health/function. Helps support/maintain visual health/function. Source of/Provides (an) antioxidant(s) for the maintenance of good health. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides an antioxidant that protects the fat in body tissues from oxidation. Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80123445
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.